Drug Markets/Crofelemer

Crofelemer

1 NDC across 1 manufacturer|0 Generic,1 Brand

Crofelemer is used to treat diarrhea, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 31, 2012. In 2024, Medicare Part D spent $8 million on Crofelemer across 2,591 claims for 376 beneficiaries.

Crofelemer is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $35.73 to $35.73 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$35.73 – $35.73

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing CROFELEMER

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
MYTESI 125 MG DR TABLET
$35.7266
per EA
—

Frequently Asked Questions

What is Crofelemer used to treat?

Crofelemer is used to treat diarrhea, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Crofelemer?

In 2024, Medicare Part D spent $8 million on Crofelemer across 2,591 claims for 376 beneficiaries.

How many Crofelemer products are on the market?

The Crofelemer drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Crofelemer?

NADAC reference prices for Crofelemer range from $35.7266 to $35.7266 per EA.

Which manufacturers make Crofelemer?

1 manufacturer lists Crofelemer in NADAC. Ranked by number of NDCs, the largest are Napo Pharmaceuticals, Inc. (1).